Business Development & Licensing Brilacidin OM phase 3 in preparation. Disagree the prospect of a partner has never looked better ! Getting clearance from FDA to proceed has derisked the investment to a prospective partner. It also makes it easier to justify investment to shareholders. With EMA green light all obstacles in past , ready for Phase 3 . Everybody knows financials are bad and need for partner. My guess partner 2 QTR, SP surprises many. (IMO)
They are working to secure better capital. No mention of a term sheet. We'll just have to wait and see what the EU discussions bring us. Hopefully not much longer MFO is for a short run.